Table 1. IVR injections for patients with PCV with refractory exudation.

Case	Age	Sex	Eye	Duration from last PDT to baseline (mon)	Previous PDT no.	Baseline			24 Months after treatment
						VA	CRT (μm)	GLD (μm)	VA	CRT (μm)	Exudation	No. of treatment	Recurrence of polypoidal lesions	No. of PDT
1	80	M	OS	3.7	1	0.2	131	8857	0.2	90	No	18	No	NA
2	75	F	OS	6.8	2	0.09	809	5324	0.2	135	No	7	No	NA
3	56	M	OS	9.6	8	0.2	232	2420	0.3	103	No	7	No	NA
4	68	M	OD	7.4	4	0.4	570	5456	0.4	158	No	11	Yes	1
5	80	M	OD	8.6	1	0.3	426	3266	0.6	122	No	4	No	NA
6	83	F	OD	41.5	3	0.7	263	4050	1.0	201	Yes	9	No	NA
7	73	M	OS	54.0	4	0.2	428	4092	0.3	87	No	3	No	NA
8	80	M	OD	6.1	2	0.4	269	2935	0.3	183	Yes	10	No	NA
9	70	M	OS	25.5	4	0.06	163	9090	0.09	59	No	3	No	NA
10	79	M	OD	3.0	2	0.15	170	6764	0.12	324	Yes	6	No	NA
11	84	M	OD	26.4	1	0.8	369	1450	0.9	137	No	8	No	NA
12	70	F	OD	13.0	5	0.15	325	3779	0.2	65	Yes	10	No	NA
13	78	M	OS	10.0	6	0.2	105	8979	0.3	88	No	18	No	NA
14	72	M	OS	31.3	3	0.4	98	5645	0.5	248	Yes	8	No	NA
15	73	M	OS	7.9	3	0.6	186	2719	0.8	222	Yes	10	No	NA
16	66	M	OD	24.5	5	0.7	232	5771	0.4	233	Yes	6	Yes	1
17	69	M	OD	18.0	1	0.3	438	5039	0.6	212	No	12	No	NA
18	76	M	OD	13.6	4	0.24	203	3088	0.2	65	No	9	Yes	1
19	80	M	OD	22.6	2	0.15	208	5380	0.6	75	No	8	Yes	1
20	76	M	OD	11.2	5	0.4	500	4733	0.5	354	Yes	8	Yes	1
21	79	M	OD	15.0	1	0.2	575	5879	0.3	494	Yes	12	No	NA
22	72	M	OD	25.9	1	0.2	227	4003	0.7	62	No	4	No	NA
23	78	M	OD	15.2	3	0.12	204	3828	0.16	52	No	3	No	NA
24	70	F	OD	3.2	1	0.5	154	5500	0.5	128	Yes	9	No	NA
25	69	M	OD	22.9	1	0.7	258	6002	0.7	124	No	14	No	NA
26	70	M	OD	13.9	1	0.9	126	3897	1.0	205	Yes	12	No	NA
Mean	74.1	—	—	17.0	2.8	0.28	295	4954	0.24	163	—	8.8	—	—
SD	6.3	—	—	12.2	1.9		174	2035		106	—	4.0	—	—

Abbreviations: F, female; M, male; OD, right eye; OS, left eye; Mon, month; SD, standard deviation; NA, not applicable, because of no retreatment with PDT.